Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

Also called NCT03980990

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03980990
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03980990. Randomized; no masking; primary purpose treatment. Start 2019-06-17 (actual); primary completion 2020-06-17 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial
Condition
Acute Coronary Syndrome
Condition
Unstable Angina
Condition
Diabetes Mellitus
Condition
Metformin Adverse Reaction
Intervention (Drug)
Metformin
Lead sponsor
University of Saskatchewan (class: other)

Record details

Record id
cardio:ct-nct03980990
Content hash
0d407bde1ae0582b07226e1b9758b9242392b698d324c4c304575cee7a881adc